As of January 22, 2025, Zentalis Pharmaceuticals (ZNTL) has a market cap of $0.16 billion USD. According to our data, Zentalis Pharmaceuticals is ranked No.7309 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.16 B |
-25.41%
|
Dec 31, 2024 | $0.22 B |
-80.00%
|
Dec 29, 2023 | $1.08 B |
-24.78%
|
Dec 30, 2022 | $1.44 B |
-76.04%
|
Dec 31, 2021 | $5.99 B |
61.84%
|
Dec 31, 2020 | $3.70 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Kura Oncology
KURA
|
$0.61 B |
0.000 M
|
USA
|
Revolution Medicines
RVMD
|
$7.56 B |
0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Syndax Pharmaceuticals
SNDX
|
$1.20 B |
0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
USA
|
C4 Therapeutics
CCCC
|
$0.26 B |
0.000 M
|
USA
|
Foghorn Therapeutics
FHTX
|
$0.24 B |
0.000 M
|
USA
|
PMV Pharmaceuticals
PMVP
|
$68.31 M |
0.000 M
|
USA
|
Market Cap | = | ZNTL Stock Price | * | ZNTL Shares Outstanding |
= | $2.26 | * | 71.27 M | |
= | $0.16 B |